Literature DB >> 10697786

Mixed infection with two types of hepatitis C virus is probably a rare event.

S Viazov1, A Widell, E Nordenfelt.   

Abstract

A search for the simultaneous presence of two hepatitis C virus (HCV) types in sera of a group of chronically infected intravenous drug users, hemodialysis patients and hemophiliacs from Sweden and Russia was performed with two genotyping methods based on the use of type-specific primers from core and NS4 regions of the viral genome. An important feature of NS4 based assay is that type-specific primers are used in both rounds of nested PCR, thus providing the possibility of the identification not only of the abundant type, but also of the minor HCV type present in a particular serum. The experiments, however, did not reveal the simultaneous presence of two or more HCV types in any of the 40 samples. These results suggest that the frequency of mixed infections in serum with different HCV types is very low even in high-risk groups, at least in the geographic region studied.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10697786     DOI: 10.1007/s150100050005

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.

Authors:  Suwanna Noppornpanth; Truong Xuan Lien; Yong Poovorawan; Saskia L Smits; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.

Authors:  Andrew J Buckton; Siew-Lin Ngui; Catherine Arnold; Katie Boast; Joanne Kovacs; Paul E Klapper; Bharat Patel; Imad Ibrahim; Savita Rangarajan; Mary E Ramsay; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 3.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

4.  Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

Authors:  Jennifer A Smith; Judith H Aberle; Vicki M Fleming; Peter Ferenci; Emma C Thomson; Peter Karayiannis; Angela R McLean; Heidemarie Holzmann; Paul Klenerman
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

5.  Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.

Authors:  Florian Douam; Louis-Marie Bobay; Guillemette Maurin; Judith Fresquet; Noémie Calland; Carine Maisse; Tony Durand; François-Loïc Cosset; Cyrille Féray; Dimitri Lavillette
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

6.  Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa.

Authors:  Joseph C Forbi; Michael A Purdy; David S Campo; Gilberto Vaughan; Zoya E Dimitrova; Lilia M Ganova-Raeva; Guo-Liang Xia; Yury E Khudyakov
Journal:  J Gen Virol       Date:  2012-03-28       Impact factor: 3.891

7.  Synonymous and nonsynonymous distances help untangle convergent evolution and recombination.

Authors:  Peter B Chi; Sujay Chattopadhyay; Philippe Lemey; Evgeni V Sokurenko; Vladimir N Minin
Journal:  Stat Appl Genet Mol Biol       Date:  2015-08

8.  A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.

Authors:  Olga Kalinina; Helene Norder; Sergey Mukomolov; Lars O Magnius
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  The genotype analysis of the hepatitis C virus in Heilongjiang Province, China.

Authors:  Xue-Di Cheng; Hua-Feng Xu; Feng Wei; Li-Xin Jiang; Hai-Zhou Zhou
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

10.  HCV genotypes of people with hemophilia in countries with high seroprevalances.

Authors:  J N Mahlangu; N Prabdial-Sing
Journal:  Iran Red Crescent Med J       Date:  2011-02-01       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.